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Abstract
Background: There is an increasing interest in using choroid plexus (CP) epithelial cell lines to study the
properties of the blood-cerebrospinal fluid barrier (BCSFB). Currently, there are three major CP-derived cell
lines available. Z310 and TR-CSFB3, two immortalized cell lines carrying the simian virus 40 large T-antigen gene,
were derived from rat CP epithelium, whereas the CPC-2 cell line was derived from human CP carcinoma.
Although these cell lines have previously been used in various functional studies, the expression of adherens
junction (AJ) and tight junction (TJ) proteins in these epithelial cells has not been systematically studied.
Accordingly, in the present study, we sought to characterize the expression of these junctional proteins in these
three cell lines.
Methods: The cells were grown in six-well cell culture plates. Reverse-transcriptase polymerase chain reaction,
Western blotting, and immunocytochemistry were used to characterize the expression of AJ and TJ proteins in
the CP cell lines.
Results: Z310 and TR-CSFB3 cells expressed a TJ protein, occludin, and its cytosolic binding partner, zonula
occludens 1, as well as an AJ protein, E-cadherin, and β-catenin, a cytoplasmic protein that interacts with E-
cadherin. However, the expression of occludin and E-cadherin in TR-CSFB3 cells at both the mRNA and protein
level was weaker than that found in Z301 cells. The immunocytochemical analysis also demonstrated that the
staining pattern for these junctional proteins in TR-CSFB3 cells was discontinuous and the staining intensity was
weaker than that observed in Z310 cells. The message for claudin 1 and claudin 2 was expressed at low levels in
TR-CSFB3 cells and these cells were weakly immunopositive for claudin 1. In comparison, the message for these
TJ proteins could not be detected in Z310 cells. CPC-2 cells expressed occludin, which was localized to areas of
cell-cell contact, but the staining pattern for this TJ protein was found to be variable and irregular. Although CPC-
2 cells expressed mRNA for claudin 1, claudin 2, and claudin 11, only claudin 1 was expressed at the protein level
and it was localized to the nuclei rather than to areas of cell-cell contact. An AJ protein, E-cadherin, was also found
to be mislocalized in CPC-2 cells, even though its cytosolic binding partner, β-catenin, was restricted to areas of
cell-cell contact, as in normal CP.
Conclusion: The three CP cell lines analyzed in this study vary considerably with regard to the expression of AJ
and TJ proteins, which is likely reflected by different barrier properties of these in vitro models of BCSFB.
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Background
There is an increasing interest in using choroid plexus
(CP) epithelial cell lines to study the properties of the
blood-cerebrospinal fluid (CSF) barrier (BCSFB). The
advantage of using the CP cell lines is not only the lower
cost associated with conducting the experiments, but also
the relative ease of growing and genetically manipulating
these cells compared to primary cultures of choroidal epi-
thelium. Currently, there are three major CP-derived cell
lines available to study the properties of the BCSFB. The
Z310 immortalized cell line was derived from primary
cultures of rat CP epithelium transfected with a plasmid
carrying the simian virus 40 (SV40) large T-antigen gene
[1]. These cells display polygonal morphology typical of
choroidal epithelial cells and form monolayers with the
transepithelial electrical resistance (TEER) varying
between ~60 and 150–200 Ω·cm2 [1,2], which is compa-
rable with the TEER values found for primary cultures of
CP epithelium from the rat [2,3]. Zheng and collaborators
have demonstrated that Z310 cells produce transthyretin
(TTR), a marker for the choroidal epithelium, and express
a number of transporters, including members of the fam-
ily of ATP-binding cassette transporters, ABCB1 (P-glyco-
protein/multidrug resistance 1) and ABCC1 (multiple
drug resistance protein 1), organic cation transporter 1,
and several metal transporters (the members of the solute
carrier superfamily of transporters), such as SLC11A2
(divalent metal transporter 1), SLC30A1 (zinc transporter
1), and SLC40A1 (metal transporting protein 1), as well as
the copper-transporting ATPase, ATP7A [1,4]. The organic
anion transporter 3 was also found to be expressed in the
Z310 line, albeit at much lower levels than those observed
in the CP.
A slightly different approach has been chosen by Teras-
aki and colleagues to establish five immortalized cell
lines of CP epithelium, TR-CSFB1-5. These cell lines
were derived from cultures of choroidal epithelial cells
harvested from transgenic rats harboring a temperature-
sensitive SV40 large T-antigen gene [5]. When grown at
the permissive temperature of 33°C, these cells form
monolayers with polygonal epithelial morphology and
TEER of ~50 Ω·cm2. Among TR-CSFB lines, the TR-
CSFB3 line was characterized with greater detail. Simi-
lar to Z310 cells, the TR-CSFB3 line synthesizes TTR and
expresses several transporters, including ABCA1 and 4,
ABCB1, ABCC1, and ABCG1 and 2, which belong to the
family of ATP-binding cassette transporters [5-9].
Organic anion transporting polypeptide 3 was also
reported to be expressed in TR-CSFB3 cells, but the lev-
els of expression of this transporter were much lower
than those found in the CP. This group has also con-
ducted biochemical studies on TR-CSFB3 cells to show
that they have the capability to actively transport L-pro-
line and L-glutamate [5].
The CPC-2 cell line was derived from human CP
carcinoma [10]. Although CPC-2 cells have not yet been
characterized with regard to barrier function, their
polypeptide secretory activity, an important feature of
choroidal epithelium [11], has been studied. CPC-2 cells
have been shown to produce endothelin 1 (ET-1) and
adrenomedullin (ADM) [12,13]. The exposure of CPC-2
cells to tumor necrosis factor-α, interleukin 1β, or a com-
bination of these two cytokines, resulted in the upregula-
tion of message for ET-1 and ADM as well as increased
secretion of these proteins into the culture media, suggest-
ing that the CPC-2 line represents a valuable in vitro model
for studying the polypeptide secretory function of the CP.
The integrity, paracellular permeability, and polarization
of epithelial monolayers depend on the expression of
adherens junction (AJ) and tight junction (TJ) proteins.
Figure 1 shows a schematic representation of AJ and TJ
complexes in choroidal epithelial cells. AJs are formed by
E-cadherin, a single pass transmembrane protein that
exhibits Ca2+-dependent homophilic interactions [14].
The intracellular domain of E-cadherin binds to β-catenin,
which binds to α-catenin, which in turn interacts with
actin, and this catenin-mediated anchorage of E-cadherin
to the actin cytoskeleton is required for strong cell-cell
adhesion [14]. E-cadherin, as well as α-catenin and β-cat-
enin, are expressed in choroidal epithelium [15]. The for-
mation of AJs plays an important role in generating the
polarized distribution of plasma membrane proteins [16]
and initiates the formation of other cell-cell junctional
complexes, such as TJs and desmosomes [17-19]. TJs form
a barrier preventing solutes from moving along the para-
cellular pathways. They also restrict the diffusion of inte-
gral membrane proteins and lipids between the apical and
basolateral plasma membrane domains [20]. Occludin
and the members of the family of claudin proteins,
belonging to the superfamily of tetraspanins (proteins
containing four transmembrane domains), are the major
constituents of TJs [20]. Occludin, as well as claudin 1,
claudin 2, and claudin 11, have been reported to be
expressed in choroidal epithelium [21,22]. Occludin and
claudins are connected to the actin filaments through
cytoplasmic adaptor proteins, zonula occludens 1–3 (ZO-
1-3), members of the membrane-associated guanylate
kinase family of proteins [20]. Interestingly, ZO-1 not
only binds to occludin and claudins, but is also able to
interact with α-catenin [23]. However, in epithelial cells
bearing well-developed TJs, ZO-1 does not co-localize
with AJs [24].
Although the Z310 cells have been partially characterized
with regard to the expression of TJ proteins [2,4], the
expression of AJ proteins in this cell line has not been ana-
lyzed. The expression of junctional proteins in other CP
epithelial cell lines, namely TR-CSFB3 and CPC-2, has notCerebrospinal Fluid Research 2007, 4:11 http://www.cerebrospinalfluidresearch.com/content/4/1/11
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been studied. Accordingly, in the present study, we sought
to characterize the expression of AJ and TJ proteins in
these three cell lines.
Methods
Reagents and antibodies
ThermoScript RNase H-  reverse transcriptase, RNase
inhibitor, RNaseOut, and Platinum Taq DNA polymerase
were obtained from Invitrogen (Carlsbad, CA, USA). Pol-
yclonal rabbit antibodies to occludin, claudin 1, claudin
2, and ZO-1 were purchased from Zymed Labs (South San
Francisco, CA, USA), whereas monoclonal mouse anti-
bodies to α-catenin,  β-catenin, and E-cadherin were
obtained from BD-Transduction Labs (Lexington, KY,
USA). For detection on Western blots, we used horserad-
ish peroxidase-conjugated anti-rabbit (from donkey) and
anti-mouse (from sheep) IgGs (Amersham Biosciences,
Piscataway, NJ, USA). Secondary antibodies for immuno-
cytochemistry were purchased from Molecular Probes
(Eugene, OR, USA). These were goat anti-rabbit and anti-
mouse IgGs conjugated with Alexa 488. Normal goat
serum was obtained from Jackson Immunoresearch Labs
(West Grove, PA, USA) and Vectashield mounting
medium for fluorescence microscopy was from Vector
Labs (Burlingame, CA, USA).
Cell lines
The Z310 cell line was kindly provided by Dr. Wei Zheng
(Purdue University, West Lafayette, IN, USA). Low-glucose
Dulbecco's modified Eagle medium (DMEM) supple-
mented with penicillin (100 U/ml), streptomycin (100 μg/
ml), gentamicin (40 μg/ml), and 10% fetal bovine serum
(FBS) was used to culture Z310 cells. They were grown to
confluence in untreated six-well cell culture plates at 37°C
in a humidified atmosphere of 5% CO2/95% air. The TR-
CSFB3 cell line was a kind gift of Dr. Tetsuya Terasaki
(Graduate School of Pharmaceutical Sciences, Tohoku
University, Sendai, Japan). TR-CSFB3 cells were cultured in
collagen I-coated plates in high-glucose DMEM supple-
mented with penicillin (100 U/ml), streptomycin (100 μg/
ml), and 10% FBS. They were initially grown at 33°C in
5% CO2/95% air and after reaching confluence were
Schematic representation of AJ and TJ complexes in choroidal epithelial cells Figure 1
Schematic representation of AJ and TJ complexes in choroidal epithelial cells. AJs are formed by E-cadherin, a single pass trans-
membrane protein that exhibits Ca2+-dependent homophilic interactions. The intracellular domain of E-cadherin binds to β-cat-
enin, which binds to α-catenin, which in turn interacts with actin, and this catenin-mediated anchorage of E-cadherin to the actin 
cytoskeleton is required for strong cell-cell adhesion. Occludin and the members of the family of claudin proteins are the major 
constituents of TJs. Occludin and claudins are connected to the actin filaments through cytoplasmic adaptor protein, ZO-1.Cerebrospinal Fluid Research 2007, 4:11 http://www.cerebrospinalfluidresearch.com/content/4/1/11
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maintained at 37°C. The CPC-2 cell line was provided by
Dr. Toshio Kudo (Cell Resource Center for Biomedical
Research, Institute of Development, Aging and Cancer,
Tohoku University, Sendai, Japan). CPC-2 cells were cul-
tured in high-glucose DMEM supplemented with penicil-
lin (100 U/ml), streptomycin (100 μg/ml), and 10% FBS.
They were grown to confluence in collagen I-coated plates
at 37°C in 5% CO2/95% air. The cell culture media, FBS,
and antibiotics were obtained from Invitrogen.
Choroid plexus tissues
Samples of the lateral ventricle CP were from Sprague-
Dawley rats (Charles River Breeding Labs, Wilmington,
MA, USA). Rats were euthanized with intraperitoneal
pentobarbital sodium (150 mg/kg), brains were removed,
and CPs subsequently excised. These procedures were in
accordance with the guidelines of the Animal Care and
Use Committee of Rhode Island Hospital and conformed
to international guidelines on the ethical use of animals.
All efforts were made to minimize the number of animals
used and their suffering. Samples of human choroidal tis-
sue were provided by Dr. Edward G. Stopa (Brown Uni-
versity Medical School, Providence, RI, USA). These were
specimens of the lateral ventricle CP from one male
patient without neurological disease. They were collected
at autopsy performed within 10 h after death. Immedi-
ately after collection, the specimens were processed for
RNA and protein extraction as described below.
Reverse-transcriptase polymerase chain reaction (RT-
PCR)
Total RNA was isolated using NucleoSpin RNA II kit
(Macherey-Nagel, Düren, Germany). First-strand cDNAs
were synthesized using 50 pmol of oligo(dT)20 primer and
15 U of ThermoScript reverse transcriptase. Forty units of
RNase inhibitor, RNaseOut, were included in the reverse
transcription reactions. For each 20-μl reaction, 1 μg of
total RNA was used and the reaction was carried out for 1
h at 50°C.
The sequences of primers and the predicted sizes of PCR
products are given in Table 1. The 25-μl PCR reaction
mixtures contained 0.2 mM mixed dNTPs, 0.2 μM each
primer, 1.5 mM MgCl2, 1 U Platinum Taq DNA polymer-
ase, and 1/40 of the reverse transcription reaction prod-
uct. The PCR reaction mixtures were heated to 95°C for 2
min and then were subjected to 30–35 cycles of denatura-
tion (94°C, 15 s), annealing (57°C, 15 s), and extension
(72°C, 15 s). A final extension was carried out at 72°C for
5 min. The PCR products (10 μl of each PCR reaction)
were separated on a 1.8% agarose gel and were visualized
by ethidium bromide staining under UV light. Control
experiments were also performed in which reverse tran-
scriptase was omitted from the reverse transcription reac-
tions and 1/40 of the product of each reaction was used
for PCR. Under these conditions, no bands were seen on
Table 1: The sequences of primers and the predicted sizes of PCR products.
Species Gene Primer Sequence
Predicted size of PCR 
product (base pairs)
Rat Occludin F 5'-GGAACACATTTATGATGAACAGC-3' 235
R 5'-CACGGACAAGGTCAGAGGAA-3'
Claudin 1 F 5'-AAAGATGTGGATGGCTGTCA-3' 189
R 5'-AGGAGGCAGAGGGAGGC-3'
Claudin 2 F 5'-AGGGTTTCCTTAGGGACAATAA-3' 196
R 5'-TAAAGTATCTGGTAGGGTTGCC-3'
Claudin 11 F 5'-CTCATCCTCCCTGGTTACG-3' 175
R 5'-GCAGAATAAGGAGCACCCC-3'
E-cadherin F 5'-AAGAAGACCAGGACTTTGATTTG-3' 169
R 5'-GCTGCCTTCAGGTTTTCATC-3'
Human Occludin F 5'-AGGAACACATTTATGATGAGCAG-3' 242
R 5'-GAAGTCATCCACAGGCGAA-3'
Claudin 1 F 5'-GAAGATGAGGATGGCTGTCA-3' 142
R 5'-AAATTCGTACCTGGCATTGA-3'
Claudin 2 F 5'-ACCATTCCTTGACGGTGTCTA-3' 121
R 5'-GCTGATTTTCCATTACGCCT-3'
Claudin 11 F 5'-TCATCCTGCCGGGCTAC-3' 174
R 5'-GCAGAATGAGCAAAACACCA-3'
E-cadherin F 5'-CCTGCCAATCCCGATGA-3' 199
R 5'-TGCCCCATTCGTTCAAGTA-3'
*F = forward; R = reverse.Cerebrospinal Fluid Research 2007, 4:11 http://www.cerebrospinalfluidresearch.com/content/4/1/11
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agarose gels for any of the genes studied with 35 cycles of
amplification (data not shown).
Western blotting
The cells were scraped into isotonic lysis buffer containing
150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 1%
SDS, 0.5% deoxycholate, 1% Triton X-100 (TX-100), 1
mM PMSF, 1 mM benzamidine, 100 U/ml aprotinin, 20
μg/ml antipain, 20 μg/ml leupeptin, and 1 μg/ml pepsta-
tin. Proteins were separated via SDS-polyacrylamide gel
electrophoresis (8% for occludin, 14% for claudin 1 and
claudin 2, and 6% for E-cadherin) under reducing condi-
tions and then were transferred onto 0.2-μm supported
nitrocellulose membranes (Bio-Rad Labs, Hercules, CA,
USA). After blocking with 5% non-fat milk for 1 h at room
temperature, the membranes were incubated with pri-
mary antibodies overnight at 4°C. The following concen-
trations of primary antibodies were used: 0.125 μg/ml for
anti-occludin antibody and 2.5 μg/ml for anti-claudin 1,
anti-claudin 2, and anti-E-cadherin antibodies. Mem-
branes were subsequently incubated with horseradish per-
oxidase-conjugated anti-rabbit (diluted 1:2,000) or anti-
mouse (diluted 1:2,500) IgG for 1 h at room temperature.
For detection, ECL chemiluminescence system (Amer-
sham Biosciences) was used.
Immunocytochemistry
For immunocytochemistry, the cells were grown on glass
cover slips. For TR-CSFB3 and CPC-2 cells, the cover slips
were precoated with collagen I. Cells were fixed with 4%
paraformaldehyde in 0.01 M phosphate-buffered saline
(PBS), pH 7.4 for 10 min at room temperature, followed
by two 5-min washes in PBS. The immunocytochemical
procedures were performed at room temperature, except
for the incubation with primary antibodies that was com-
pleted at 4°C. All incubations were performed in PBS con-
taining 0.25% bovine serum albumin (BSA) and 0.25%
TX-100. For washes, PBS containing 0.1% BSA and 0.1%
TX-100 was used. To minimize non-specific staining, the
cells were incubated for 30 min with 10% normal goat
serum. Four percent of normal goat serum was also added
when the cells were incubated with primary and second-
ary antibodies. After the initial blocking step, the cells
were incubated overnight with primary antibodies. The
following concentrations of primary antibodies were
used: 0.25 μg/ml for anti-occludin antibody, 0.5 μg/ml for
anti-ZO-1 and anti-E-cadherin antibodies, and 2.5 μg/ml
for anti-claudin 1, anti-claudin 2, anti-α-catenin, and anti-
β-catenin antibodies. Six 10-min washes were then per-
formed and the cells were incubated for 1 h with second-
ary antibodies at a concentration of 2 μg/ml. After four 10-
min washes, the cells were mounted with Vectashield
mounting medium. The cells were viewed with a fluores-
cence microscope (Olympus, Model BH2-RFCA).
Results
Results are summarized in Table 2.
RT-PCR analysis
The expression levels of TJ proteins, occludin and clau-
dins, and an AJ protein, E-cadherin, varied considerably
among the studied cell lines. Based on previous observa-
tions that claudin 1, claudin 2, and claudin 11 are
expressed in rodent CP [21,22], we focused our analysis
on these three members of the claudin family. None of
these TJ proteins were found to be expressed in Z310 cells
derived from rat CP (Fig. 2A). In another epithelial cell
line derived from rat CP, the TR-CSFB3 line, claudin 1 and
claudin 2 were weakly expressed, but the message for clau-
din 11 was not detected (Fig. 2A). In comparison, in
human CPC-2 cells, all three members of the claudin fam-
ily were expressed (Fig. 2B). Unlike claudins, occludin was
expressed in all three cell lines (Figs. 2A and 2B). Simi-
larly, the message for E-cadherin was expressed in rat and
human CP cell lines (Figs. 2A and 2B).
Western blotting
The expression of claudins at the protein level did not
consistently reflect their expression at the mRNA level.
Although the message for claudin 1 and claudin 2 was
Table 2: Summary of results.
Junctional 
protein
Z310 cells TR-CSFB3 cells CPC-2 cells
mRNA RT-
PCR
Protein WB Protein ICC MRNA RT-
PCR
Protein WB Protein ICC mRNA RT-
PCR
Protein WB Protein ICC
Occludin + + + + + + + + +
Claudin 1 - - - + - + + + +*
Claudin 2 - - - + - - + - -
Claudin 11 - ND ND - ND ND + ND ND
ZO-1 ND ND + ND ND + ND ND -
E - c a d h e r i n +++++++-+ *
α-Catenin ND ND + ND ND - ND ND -
β-Catenin ND ND + ND ND + ND ND +
* = mislocalized; WB = Western blotting; ICC = immunocytochemistry; ND = not determined.Cerebrospinal Fluid Research 2007, 4:11 http://www.cerebrospinalfluidresearch.com/content/4/1/11
Page 6 of 10
(page number not for citation purposes)
found in TR-CSFB3 cells, these two members of the clau-
din family could not be detected in protein extracts from
these cells on immunoblots (Figs. 3A and 3B). Similarly,
claudin 2 was not detected in protein extracts from CPC-2
cells even though the message for this TJ protein was
found in this cell line (Fig. 3B). In comparison, claudin 1
was found to be expressed in CPC-2 cells at both the
mRNA and protein level (Fig. 3A). Neither claudin 1 nor
claudin 2 could be detected in protein extracts from Z310
cells (Figs. 3A and 3B), which was consistent with the data
obtained from mRNA analysis. As expected, claudin 2 was
detected as a ~22-kDa protein in the rat and human
choroidal tissues; however, an additional band with
higher molecular weight was also consistently observed
on immunoblots, which may have represented the glyco-
sylated form of claudin 2. Occludin was detected as a ~65-
kDa protein; however, additional bands with both lower
and higher molecular weight and lower intensity (except
for Z310 cells) were found on immunoblots (Fig. 3C).
These multiple bands are likely to represent various iso-
forms of occludin resulting from alternative splicing
events [25]. In TR-CSFB3 cells, occludin was found to be
expressed at a lower level compared to other two lines
(Fig. 3C). E-cadherin was detected on immunoblots as a
~120-kDa protein (Fig. 3D). Interestingly, an additional
band of ~135 kDa was also found in protein extracts from
rat choroidal tissue and Z310 cells. This additional band
may represent a precursor of E-cadherin [26]. E-cadherin
was only weakly expressed in TR-CSFB3 cells and could
not be detected in protein extracts from CPC-2 line
(Fig. 3D).
Immunocytochemistry
Z310 cells
Z310 cells had cobblestone-like morphology typical of
CP epithelium. As expected, based on RT-PCR analysis
and Western blotting, the Z310 line expressed occludin
and E-cadherin, and these proteins were found to be
localized to areas of cell-cell contact in confluent monol-
ayers with a continuous pattern of immunostaining (Fig.
4A). We also showed that Z310 cells express ZO-1, a
cytoplasmic adaptor protein binding to claudins and
occludin [23], and α-catenin and β-catenin, the E-cad-
herin interacting proteins [14]. Similar to occludin and
E-cadherin, ZO-1 and catenins had a continuous pattern
of immunostaining and were localized to areas of cell-
cell contact (Fig. 4A). Consistent with the RT-PCR
results, the Z310 cells did not stain for claudin 1 and
claudin 2 (data not shown).
Western blot analysis of expression of junctional proteins in  CP cell lines Figure 3
Western blot analysis of expression of junctional proteins in 
CP cell lines. A, B, and C. Expression of TJ proteins, claudin 
1, claudin 2, and occludin. D. Expression of AJ protein, E-cad-
herin. Z310 and TR-CSFB3 cell lines were derived from rat 
CP epithelium, whereas the CPC-2 cell line was derived from 
human CP carcinoma. The amount of protein loaded is 
shown for each lane. rCP and hCP are rat and human CP tis-
sues used as a positive control.
RT-PCR analysis of expression of junctional proteins in CP  cell lines Figure 2
RT-PCR analysis of expression of junctional proteins in CP 
cell lines. A. Expression of TJ and AJ proteins in Z310 and 
TR-CSFB3 cells, two immortalized cell lines derived from rat 
CP epithelium. B. Expression of TJ and AJ proteins in the 
CPC-2 cell line derived from human CP carcinoma. The 
number of cycles of amplification is shown for each lane. 
Cldn 1, Cldn 2, Cldn 11, Ocln, and E-cdh are claudin 1, 
claudin 2, claudin 11, occludin, and E-cadherin, respectively. 
rCP and hCP are rat and human CP tissues used as a positive 
control.Cerebrospinal Fluid Research 2007, 4:11 http://www.cerebrospinalfluidresearch.com/content/4/1/11
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TR-CSFB3 cells
TR-CSFB3 cells formed less regular monolayers com-
pared to Z310 cells. Similar to Z310 cells, they expressed
occludin and E-cadherin, which were localized to areas
of cell-cell contact. However, the pattern of this immu-
nostaining was frequently discontinuous and the inten-
sity of staining was weaker than that found in Z310 cells
(Fig. 4B). Interestingly, the TR-CSFB3 cells were also
found to weakly stain for claudin 1 (Fig. 4B), even
though this TJ protein could not be detected in protein
extracts from these cells by Western blotting. This dis-
crepancy reflects the higher sensitivity of immunofluo-
rescence technique compared to immunoblotting. TR-
CSFB3 cells did not stain for claudin 2 (data not shown),
suggesting that the message for this TJ protein is ineffi-
ciently translated in these cells. Similar to Z310 cells, the
TR-CSFB3 line was found to be immunopositive for ZO-
1 and β-catenin (Fig. 4B), but it did not express α-catenin
(data not shown). Although ZO-1 and β-catenin were
found to be localized to areas of cell-cell contact, the pat-
tern of immunostaining for these two proteins was dis-
continuous and the intensity of staining was weaker than
that found in Z310 cells (Fig. 4B).
CPC-2 cells
Similar to TR-CSFB3 cells, the CPC-2 line formed less reg-
ular monolayers compared to Z310 cells. In addition, the
CPC-2 cells were larger in size than Z310 and TR-CSFB3
cells. Although they expressed occludin, which was local-
ized to areas of cell-cell contact, the staining pattern for
this TJ protein was variable and irregular (Fig. 4C). As
expected, based on both RT-PCR and Western blotting,
the CPC-2 cells expressed claudin 1; however, this TJ pro-
tein was found to be restricted to the nuclei of these epi-
thelial cells (Fig. 4C). CPC-2 cells did not stain for claudin
2 or ZO-1 (data not shown). E-cadherin was expressed in
CPC-2 line, but the immunoreactive product for this AJ
protein was not localized to areas of cell-cell contact (Fig.
4C). Interestingly, β-catenin, a cytosolic protein that binds
to E-cadherin [14], was localized to areas of cell-cell con-
tact; however, similar to occludin, the staining pattern for
β-catenin was variable and irregular (Fig. 4C). Another
member of AJ complex, α-catenin, was not detected in
CPC-2 cells (data not shown).
Discussion
In the present study, the junctional proteins in two
immortalized epithelial cell lines derived from rat CP
were analyzed. Although the same oncogene (SV40 large
T-antigen) was used to generate the Z310 and TR-CSFB3
lines, these two CP cell lines differ with regard to expres-
sion of junctional proteins. Both cell lines were found to
express a TJ protein, occludin, and its cytosolic binding
partner, ZO-1, as well as an AJ protein, E-cadherin, and
β-catenin, a cytoplasmic protein that interacts with E-
cadherin. However, the expression of occludin and E-
cadherin in TR-CSFB3 cells at both the mRNA and pro-
tein level was weaker than that found in Z301 cells. The
immunocytochemical analysis also demonstrated that
the staining pattern for these junctional proteins in TR-
CSFB3 cells was discontinuous and the staining intensity
was weaker than that observed in Z310 cells. Interest-
ingly, the mRNA for claudin 1 and claudin 2 was
expressed at low levels in TR-CSFB3 cells and these cells
Immunocytochemical analysis of expression of junctional  proteins in CP cell lines Figure 4
Immunocytochemical analysis of expression of junctional 
proteins in CP cell lines. A and B. Z310 and TR-CSFB3 cell 
lines derived from rat CP epithelium. C. CPC-2 cell line 
derived from human CP carcinoma. Scale bars = 10 μm.Cerebrospinal Fluid Research 2007, 4:11 http://www.cerebrospinalfluidresearch.com/content/4/1/11
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were only weakly immunopositive for claudin 1. In com-
parison, in Z310 cells, the message for these TJ proteins
could not be detected, which was consistent with the
results of a previous study by Shi and Zheng [2]. Our
findings are in line with observations that the expression
of TJ and AJ proteins in immortalized epithelial cells car-
rying the SV40 large T-antigen gene can vary considera-
bly. For example, gastric and colonic epithelial cell lines
have been reported to express high levels of ZO-1 and E-
cadherin [27,28], whereas introduction of the SV40 large
T-antigen gene to uterine epithelial cells resulted in the
loss of these junctional proteins [29].
The CPC-2 cell line was derived from human CP carci-
noma [10]. These epithelial cells express occludin, which
is localized to areas of cell-cell contact, but the staining
pattern for this TJ protein was found to be variable and
irregular. Although the CPC-2 cells express mRNA for
claudin 1, claudin 2, and claudin 11, only claudin 1 was
found to be expressed at the protein level and it was
localized to the nuclei rather than to areas of cell-cell
contact, as in normal CP [21,22]. An AJ protein, E-cad-
herin, was also found to be mislocalized in CPC-2 cells,
and α-catenin, a component of the AJ complex, could
not be detected. These results are consistent with fre-
quently observed dysregulation of AJ complexes occur-
ring in carcinoma cells [30] and are in line with
previously reported disruption of TJs caused by onco-
genes [31]. Similar to our findings, a recent study has
demonstrated the nuclear localization of claudin 1 in a
number of carcinoma cells [32]. Unexpectedly, overex-
pression of claudin 1 in a colon carcinoma line express-
ing low levels of this TJ protein and having epithelioid
morphology resulted in the redistribution of E-cadherin
from areas of cell-cell contact and epithelial-mesenchy-
mal transition of these cells. These latter findings suggest
that, under certain conditions, claudin 1 may act to
weaken the epithelial barrier.
Interestingly, β-catenin, a cytosolic protein, was found to
be restricted to areas of cell-cell contact in CPC-2 cells,
even though E-cadherin, an integral membrane protein
and the binding partner for β-catenin, had a different cel-
lular distribution. These observations are similar to those
previously reported for a human breast epithelial cell line
transfected with the Ha-Ras protooncogene, where β-cat-
enin and E-cadherin did not co-localize in areas of cell-cell
contact [33]. These findings raise an important question
as to which membrane-associated protein β-catenin binds
to in CPC-2 cells. One possible candidate is the epidermal
growth factor receptor, which has previously been shown
to regulate the function of AJs [34] and to interact with β-
catenin [35].
Similar to CP tissues from rats and humans, in all three CP
cell lines studied, occludin was detected on immunoblots
as a ~65-kDa protein. However, in both rat and human CP
tissues and in Z310 cells, additional bands were detected
with anti-occludin antibody. These findings are in line
with previous observations that multiple isoforms of
occludin are generated as a result of alternative splicing
events [25]. Among these multiple isoforms, two occludin
variants have been found that lacked the fourth trans-
membrane domain. These variants did not co-localize
with ZO-1. Furthermore, a new promoter and transcrip-
tion start site have been identified, adding to the structural
diversity of occludin variants. The physiological signifi-
cance of the presence of multiple isoforms of occludin is
presently unclear.
Unlike occludin, claudin 2 protein was not found to be
expressed in any of the cell lines analyzed in the present
study. Although claudin 2 appears to be an important
component of TJ complexes in choroidal epithelium
[21,22], recent studies have suggested that claudin 2 can
actually decrease the tightness of epithelial barrier by act-
ing as a cation-selective channel [36]. At present, the func-
tional role of claudin 2 in the choroidal epithelium is not
clear, but this TJ protein may play a role in the process of
CSF formation because of its cation channel properties
[37]. Since claudin 2 can substantially decrease TEER of
epithelial monolayers [36], its lack of expression in CP
cell lines may in fact result in the enhancement of barrier
properties of these in vitro models of BCSFB.
Conclusion
The three CP cell lines analyzed in this study vary consid-
erably with regard to the expression of AJ and TJ proteins,
which is likely reflected by different barrier properties of
these in vitro models of BCSFB.
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